Brokerages Set Mettler-Toledo International Inc. (NYSE:MTD) PT at $1,363.75

Mettler-Toledo International Inc. (NYSE:MTD - Get Free Report) has earned a consensus rating of "Reduce" from the eight analysts that are presently covering the firm, MarketBeat.com reports. Two investment analysts have rated the stock with a sell recommendation, five have given a hold recommendation and one has issued a buy recommendation on the company. The average 1 year target price among brokerages that have covered the stock in the last year is $1,363.75.

Several research analysts have issued reports on the company. Wells Fargo & Company initiated coverage on Mettler-Toledo International in a report on Tuesday, August 27th. They set an "equal weight" rating and a $1,400.00 price objective on the stock. The Goldman Sachs Group boosted their target price on Mettler-Toledo International from $1,150.00 to $1,300.00 and gave the stock a "neutral" rating in a research report on Tuesday, July 9th. StockNews.com raised shares of Mettler-Toledo International from a "hold" rating to a "buy" rating in a research note on Thursday, July 11th. JPMorgan Chase & Co. lifted their price target on shares of Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the stock a "neutral" rating in a research report on Monday, August 5th. Finally, Evercore ISI boosted their price target on shares of Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the company an "in-line" rating in a report on Tuesday, October 1st.

Insiders Place Their Bets

In other news, insider Christian Magloth sold 1,000 shares of the company's stock in a transaction dated Thursday, August 15th. The stock was sold at an average price of $1,422.97, for a total transaction of $1,422,970.00. Following the completion of the transaction, the insider now directly owns 734 shares of the company's stock, valued at $1,044,459.98. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In other news, CFO Shawn Vadala sold 250 shares of the stock in a transaction dated Wednesday, August 7th. The shares were sold at an average price of $1,401.00, for a total transaction of $350,250.00. Following the completion of the transaction, the chief financial officer now directly owns 4,914 shares in the company, valued at $6,884,514. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Christian Magloth sold 1,000 shares of Mettler-Toledo International stock in a transaction dated Thursday, August 15th. The shares were sold at an average price of $1,422.97, for a total value of $1,422,970.00. Following the completion of the sale, the insider now directly owns 734 shares in the company, valued at approximately $1,044,459.98. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.94% of the company's stock.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the stock. Assetmark Inc. boosted its holdings in shares of Mettler-Toledo International by 14.1% in the 3rd quarter. Assetmark Inc. now owns 437 shares of the medical instruments supplier's stock valued at $655,000 after buying an additional 54 shares during the last quarter. Verdence Capital Advisors LLC lifted its stake in Mettler-Toledo International by 18.8% in the third quarter. Verdence Capital Advisors LLC now owns 202 shares of the medical instruments supplier's stock valued at $303,000 after acquiring an additional 32 shares during the last quarter. Applied Finance Capital Management LLC grew its position in shares of Mettler-Toledo International by 2,952.5% in the 3rd quarter. Applied Finance Capital Management LLC now owns 15,629 shares of the medical instruments supplier's stock valued at $23,439,000 after acquiring an additional 15,117 shares during the period. CWA Asset Management Group LLC acquired a new position in shares of Mettler-Toledo International during the 3rd quarter worth about $1,428,000. Finally, PDS Planning Inc bought a new stake in shares of Mettler-Toledo International in the 3rd quarter valued at about $211,000. 95.07% of the stock is currently owned by institutional investors.

Mettler-Toledo International Stock Up 3.9 %

NYSE:MTD traded up $50.34 during trading hours on Friday, reaching $1,342.09. The company had a trading volume of 173,842 shares, compared to its average volume of 132,531. Mettler-Toledo International has a one year low of $953.28 and a one year high of $1,546.93. The stock has a 50-day moving average of $1,403.38 and a two-hundred day moving average of $1,394.26. The firm has a market capitalization of $28.48 billion, a PE ratio of 36.93, a PEG ratio of 3.81 and a beta of 1.14.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last announced its quarterly earnings results on Thursday, August 1st. The medical instruments supplier reported $9.65 earnings per share (EPS) for the quarter, beating the consensus estimate of $9.00 by $0.65. The firm had revenue of $946.75 million during the quarter, compared to the consensus estimate of $929.13 million. Mettler-Toledo International had a net margin of 20.95% and a negative return on equity of 575.61%. The firm's quarterly revenue was down 3.6% on a year-over-year basis. During the same period last year, the firm posted $10.19 EPS. As a group, sell-side analysts expect that Mettler-Toledo International will post 40.34 earnings per share for the current year.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.